Compared with those on oral therapies, patients with psoriasis on biologics earn higher wages, primarily due to the increased number of work hours by those on biologic therapies. This according to a new population-based study that compared personal economic indicators between patients with psoriasis on biologic therapies and those on oral medications. A multivariate linear, regression analysis revealed the following:
- The number of US respondents with psoriasis who reported using biologic or oral therapies between 2003 -2015 was 2,638,681.
- The mean annual wage among patients on biologics was significantly higher vs those on oral therapies.
- The mean weekly hours worked among patients on biologics was significantly higher vs patients on oral therapies.
Nguyen K, et al. Differences in wage earning between psoriasis patients on biologics versus those on oral therapies: A population-based study in the United States. [Published online ahead of print September 26, 2019]. J Dermatolog Treat. doi: 10.1080/09546634.2019.1666966.